Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2009 1
2010 2
2011 1
2012 2
2013 2
2014 1
2015 1
2016 3
2017 6
2018 8
2019 8
2020 6
2021 18
2022 13
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial.
Neuberger M, Kowalewski KF, Simon V, von Hardenberg J, Siegel F, Wessels F, Worst TS, Michel MS, Westhoff N, Kriegmair MC, Honeck P, Nuhn P. Neuberger M, et al. Among authors: von hardenberg j. Eur Urol Oncol. 2024 Feb;7(1):53-62. doi: 10.1016/j.euo.2023.07.009. Epub 2023 Aug 4. Eur Urol Oncol. 2024. PMID: 37543465 Clinical Trial.
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study.
Sigle A, Borkowetz A, von Hardenberg J, Drerup M, Kornienko K, Kwe J, Wenzel M, Mandel P, Westhoff N, Rieger C, Hoffmann MA, Ortner G, Mahjoub S; GeSRU Academics Prostate Cancer Group. Sigle A, et al. Among authors: von hardenberg j. Eur Urol Focus. 2023 Jul;9(4):606-613. doi: 10.1016/j.euf.2023.01.020. Epub 2023 Feb 17. Eur Urol Focus. 2023. PMID: 36804191
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany.
Wenzel M, Borkowetz A, Lieb V, Hoffmann MA, Borgmann H, Höfner T, Dotzauer R, Neuberger M, Worst TS, von Hardenberg J, Linxweiler J, Klümper N. Wenzel M, et al. Among authors: von hardenberg j. Urol Oncol. 2022 Dec;40(12):538.e7-538.e14. doi: 10.1016/j.urolonc.2022.09.011. Epub 2022 Oct 14. Urol Oncol. 2022. PMID: 36244915
Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.
Neuberger M, Skladny J, Goly N, Wessels F, WEIß C, Egen L, Erben P, GROß-Weege M, Grüne B, Hartung F, Herrmann J, Honeck P, Jarczyk J, Kowalewski KF, Mühlbauer J, Nitschke K, Nientiedt M, Walach MT, Waldbillig F, Westhoff N, VON Hardenberg J, Kriegmair M, Worst TS, Nuhn P. Neuberger M, et al. Among authors: von hardenberg j. Anticancer Res. 2022 Apr;42(4):1911-1918. doi: 10.21873/anticanres.15668. Anticancer Res. 2022. PMID: 35347010
Reply to Hsiao-Chun Chang and Shiu-Dong Chung's Letter to the Editor re: Britta Grüne, F abian Siegel, Frank Waldbillig, et al. Long-term Reinterventions after Thulium Laser Enucleation of the Prostate: 12-Year Experience with more than 1000 Patients. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.12.006.
Grüne B, von Hardenberg J. Grüne B, et al. Among authors: von hardenberg j. Eur Urol Focus. 2022 Nov;8(6):1866. doi: 10.1016/j.euf.2022.03.003. Epub 2022 Mar 17. Eur Urol Focus. 2022. PMID: 35307320 No abstract available.
67 results